COVID-19 Related Publications Focusing on Cancer: Systematic Review of a Delicate Balance

Abstract

The ongoing COVID-19 pandemic has forced oncologists to alter their daily practice, despite the lack of substantial evidence, in order to reduce the risk of transmission among patients with underlying malignant and other concurrent medical conditions. This systematic review compares the characteristics of oncology-focused COVID-19 manuscripts published from January 1st to April 30th, 2020, and from September 1st to September 30th, 2020, to identify the variation of publications between the start of the pandemic and our current state. The PubMed database was searched on two different occasions using the search string “Cancer OR Tumor” AND “COVID-19 OR SARS-CoV-2”. All manuscripts pertaining to COVID-19 and oncological topics were included in this review. The search from January 1st to April 30th, 2020 and from September 1st to September 30th, 2020, resulted in 299 and 249 articles pertaining to our objective, respectively. Comparing the earlier with later publication period, the proportion of articles containing original data increased from 22.4% to 44.2%, whereas the proportion of Editorials/Correspondences decreased from 43.5% to 20.5%. Cancer patient management guidelines accounted for the majority of publications during both periods (59.2% versus 43.4%, respectively). The study revealed a rapidly increasing number of COVID-19 and oncological-focused publications through-out the pandemic thus far. Given the unprecedented nature of the COVID-19 pandemic, future analyses are expected to reveal rapidly evolving publication patterns.